Hendrik Schlehahn joined us on August 3, 2020 as Managing Director of our German subsidiary Panpharma GmbH. Hendrik has 23 years of experience in the pharmaceutical industry. From 2000 to 2012 he held various responsibilities in production / technical and quality assurance at the GSK / Aspen site in Bad Oldesloe and since 2013 he …
News
Gender Equality Index
December 2020 | Company
Since the creation of Panpharma in 1983, women have always been at the forefront of the company, particularly in strategic positions. While the glass ceiling that often keeps women out of top management still exists, at Panpharma we are proud to have a Management Committee that respects equality and in which 50% of the members …
The teams in Boulogne-Billancourt move to Saint Cloud
July 2020 | Company
The teams in Boulogne have moved into new, larger offices in Saint Cloud. In addition to an individualized and quiet working space for each employee, these new, bright premises have 3 meeting rooms, 2 of which are equipped with a video-conference system and a kitchen-cafeteria area.
Management of the health crisis, Covid-19
March 2020 | Company
Panpharma, a pharmaceutical company, manufactures a wide range of injectable medicinal products of Major Therapeutic Interest that are vital to the hospital care of many patients, both generally and for the treatment of opportunistic respiratory and cardiac diseases related to Covid-19. Cognisant and proud of this responsibility, the Panpharma teams, further to government instructions, have …
Panpharma has been one of the « 500 mid-size champions »
January 2020 | Non classé
Panpharma has been one of the « 500 mid-size champions » invited by the French President Emmanuel Macron at Elysée palace last Tuesday January 21, 2020 (see picture below). « This is a great satisfaction for Panpharma and its team. It is a major recognition of our commitment to Public Health for more than 35 …
One Group, One name
October 2019 | Company
For several months now, we have been working on changing the name of our German subsidiary Rotexmedica GmbH in order to present one united identity to our partners. As a result, Rotexmedica officially became Panpharma GmbH on 29 August 2019.This is simply a change of name. The legal entity (the company) remains the same.The legal …
Work experience
March 2019 | Company
Between 5 and 7 March 2019, Panpharma participated in the Classes en Entreprise work experience programme for the second year in succession, hosting at the Luitré site twenty-seven Year 10 students from Thérèse Pierre de Fougères School. Coordinated by the Union des Entreprises 35 business association in partnership with Rennes Academy, the Departmental Council and …
Open House in Luitré
October 2018 | Company
Open house took place on Saturday, October 6 at our Luitré site for the employees and their families. It was an opportunity for each employee to present their work to their family and friends. Nearly 320 people were able to get acquainted with the production and quality control laboratory. In addition to the families of …
The Panpharma Group will be attending CPhI Worldwide (Convention on Pharmaceutical Ingredients)
July 2018 | Company
From 09 to 11 October 2018, CPhI will bring the key players in the pharmaceutical industry together in Madrid, Spain. The Panpharma teams will be there to meet you and welcome you to our stand no. 14.OC71
Panpharma launches Heparin calcium onto the French market
July 2018 | Product
Heparin is a biological product of natural origin that we have been producing and distributing all over the world for some time. In addition to the heparin sodium range (intravenous administration) that we already distribute, as of this year we are marketing 5 new presentations of Heparin calcium (subcutaneous administration) in France: 3 presentations in …